BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$3.67B |
| 2 |
S&P Global
SPGI
|
+$3.35B |
| 3 |
Tesla
TSLA
|
+$2.24B |
| 4 |
Microsoft
MSFT
|
+$1.42B |
| 5 |
JPMorgan Chase
JPM
|
+$1.39B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$4.51B |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$3.67B |
| 3 |
Meta Platforms (Facebook)
META
|
+$2.03B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.49B |
| 5 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$1.33B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.94% |
| 2 | Healthcare | 13.65% |
| 3 | Financials | 12.55% |
| 4 | Consumer Discretionary | 10.62% |
| 5 | Industrials | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TARO
3651
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $7.52M | ﹤0.01% |
173,766
-3,904
| -2% | -$182K |
|
3652
Cadre Holdings
CDRE
$1.32B
| $7.51M | ﹤0.01% |
305,937
+37,547
| +14% | +$848K |
|
|
SURF
3653
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $7.49M | ﹤0.01% |
2,548,105
-14,580
| -0.6% | -$51.1K |
|
|
INFI
3654
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $7.49M | ﹤0.01% |
6,569,410
-98,093
| -1% | -$117K |
|
|
BFIN
3655
DELISTED
BankFinancial
BFIN
| $7.46M | ﹤0.01% |
719,989
+53,370
| +8% | +$579K |
|
|
RENT
3656
Rent the Runway
RENT
$121M
| $7.44M | ﹤0.01% |
54,008
+4,609
| +9% | +$541K |
|
3657
Compugen
CGEN
$222M
| $7.4M | ﹤0.01% |
2,299,440
+496
| +0% | +$1.68K |
|
3658
Tarsus Pharmaceuticals
TARS
$2.58B
| $7.4M | ﹤0.01% |
439,958
-9,000
| -2% | -$167K |
|
3659
West Fraser Timber
WFG
$5.08B
| $7.38M | ﹤0.01% |
89,586
+66,401
| +286% | +$6.24M |
|
3660
Park-Ohio Holdings
PKOH
$575M
| $7.38M | ﹤0.01% |
524,727
-11,968
| -2% | -$216K |
|
3661
iShares Short-Term National Muni Bond ETF
SUB
$11.4B
| $7.38M | ﹤0.01% |
70,559
-1,268,832
| -95% | -$134M |
|
3662
Oaktree Specialty Lending
OCSL
$1.02B
| $7.37M | ﹤0.01% |
333,397
-24,488
| -7% | -$548K |
|
|
SRTA
3663
Strata Critical Medical Inc
SRTA
$434M
| $7.37M | ﹤0.01% |
868,060
-8,174
| -0.9% | -$57.4K |
|
3664
Escalade
ESCA
$273M
| $7.36M | ﹤0.01% |
557,245
-8,827
| -2% | -$124K |
|
3665
Amylyx Pharmaceuticals
AMLX
$2.26B
| $7.35M | ﹤0.01% |
+572,341
| New | +$12.9M |
|
|
IMDX
3666
Insight Molecular Diagnostics
IMDX
$150M
| $7.35M | ﹤0.01% |
246,682
-2,975
| -1% | -$95.1K |
|
|
CDR
3667
DELISTED
Cedar Realty Trust, Inc
CDR
| $7.34M | ﹤0.01% |
265,689
-3,474
| -1% | -$87.2K |
|
3668
New Mountain Finance
NMFC
$651M
| $7.33M | ﹤0.01% |
529,560
-109,422
| -17% | -$1.48M |
|
3669
Quantum-Si Incorporated
QSI
$155M
| $7.31M | ﹤0.01% |
1,562,495
+29,793
| +2% | +$145K |
|
3670
Remitly
RELY
$4.79B
| $7.28M | ﹤0.01% |
737,373
-158,695
| -18% | -$1.89M |
|
3671
Prelude Therapeutics
PRLD
$366M
| $7.26M | ﹤0.01% |
1,051,960
+155,456
| +17% | +$1.42M |
|
|
MPX
3672
DELISTED
Marine Products Corp
MPX
| $7.24M | ﹤0.01% |
626,784
+2,132
| +0.3% | +$25.8K |
|
|
VIA
3673
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $7.23M | ﹤0.01% |
175,499
+1,953
| +1% | +$104K |
|
3674
indie Semiconductor
INDI
$682M
| $7.2M | ﹤0.01% |
921,562
+35,596
| +4% | +$292K |
|
|
TBHC
3675
DELISTED
The Brand House Collective
TBHC
| $7.2M | ﹤0.01% |
774,665
-25,916
| -3% | -$369K |
|
Similar funds
BlackRock's Q1 2022 Portfolio in Review
As of Q1 2022, BlackRock held 6,014 positions worth $3.71T, down 5.5% from $3.93T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
BlackRock's Q1 2022 filing shows 170 new, 2,466 increased, 2,626 reduced and 167 closed positions. Its largest new stake was Constellation Energy: 21,495,337 shares worth $1.21B. The largest sale was Xilinx Inc, an estimated $4.51B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q1 2022 buy was Constellation Energy: 21,495,337 shares worth $1.21B.
- BlackRock added most to Advanced Micro Devices in Q1 2022, an estimated $3.67B increase.
- BlackRock's biggest Q1 2022 reduction was Meta Platforms (Facebook), cutting an estimated $2.03B.
- BlackRock fully exited Xilinx Inc in Q1 2022, selling an estimated $4.51B.
- BlackRock's ten largest holdings make up 21% of its $3.71T portfolio in Q1 2022.
- BlackRock opened 170 new positions and closed 167 in Q1 2022.
- BlackRock's portfolio value fell 5.5% quarter-over-quarter to $3.71T.
Based on BlackRock's 13F filing for Q1 2022, filed 12 May 2022.